Stibbe advised Breakthrough Properties

NL Law

Breakthrough Properties, the global life sciences real estate developer, is expanding its European footprint and will develop Neogene Therapeutics’ new European headquarters within the campus of the Amsterdam University Medical Centre (Amsterdam UMC). Kavel F by Breakthrough is expected to become one of the most advanced and sustainable laboratory environments in the world.

Kavel F by Breakthrough is a testament to their vision of building the future of life sciences, and their commitment to sustainability, biodiversity and occupant health and wellness.

Stibbe advised Breakthrough Properties on the acquisition of Kavel F, the construction agreement and the lease and development agreement with Neogene Therapeutics.